…
Atlas Energy Corp., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. The company was formerly known as Willow Biosciences Inc. and changed its name to Atlas Energy Corp. in June 2025. Atlas Energy Corp. was founded in 2019 and is headquartered in Calgary, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Atlas Energy Corp. (ATLE.V) are limited; available filings indicate it operates in the Canadian energy sector with a focus on upstream oil and gas assets. Long-term growth drivers may include commodity price trends, successful development of its resource base and cost control, which could support production and cash flow; investors may find small-cap exposure to upstream energy attractive for diversification despite higher volatility.
Key risks include commodity price volatility, limited disclosure and market liquidity, execution and operational challenges inherent to upstream producers, and potential financing constraints.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -2.59M | -2.27M | -13.03M | -14.76M | -6.14M |
| Net income | -1.37M | -6.19M | -13.03M | -14.81M | -6.14M |
| Selling general administrative | 2.74M | 2.12M | 6.02M | 9.10M | 8.60M |
| Reconciled depreciation | 0.03M | 1.39M | 1.83M | 2.65M | 3.19M |
| Operating income | -2.77M | -2.18M | -13.48M | -18.40M | -23.17M |
| Interest expense | 0.06M | 0.14M | 0.14M | 0.03M | 0.03M |
| Tax provision | - | 0.00M | -0.01M | 0.05M | 0.00M |
| Interest income | 0.39M | 0.06M | 0.27M | 0.30M | 0.41M |
| Net interest income | 0.33M | -0.09M | 0.12M | 0.27M | 0.39M |
| Total revenue | 0.00M | 0.00M | 1.17M | 0.82M | 0.13M |
| Total operating expenses | 2.77M | 2.18M | 14.65M | 19.22M | 23.31M |
| Total other income expense net | -0.14M | -0.01M | 0.32M | 3.37M | 16.65M |
| Net income from continuing ops | -2.59M | -2.27M | -13.03M | -14.81M | -6.14M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 27.67M | 2.49M | 6.67M | 18.15M | 35.02M |
| Total liab | 0.38M | 2.99M | 3.24M | 1.77M | 5.33M |
| Total stockholder equity | 27.28M | -0.51M | 3.44M | 16.37M | 29.68M |
| Capital stock | 30.29M | 120.89M | 118.18M | 118.07M | 118.03M |
| Retained earnings | -9.84M | -127.87M | -121.69M | -108.66M | -93.84M |
| Cash | 27.46M | 0.33M | 3.15M | 11.01M | 30.12M |
| Total current liabilities | 0.38M | 1.99M | 1.73M | 1.72M | 1.41M |
| Net debt | - | 0.38M | - | - | - |
| Short long term debt | - | - | 0.08M | - | - |
| Total current assets | 27.67M | 0.66M | 4.17M | 16.23M | 31.27M |
| Short term investments | 0.02M | 0.02M | 0.02M | 4.02M | 0.00M |
| Net receivables | 0.06M | 0.04M | 0.17M | 0.28M | 0.04M |
| Long term debt | - | 0.71M | 0.68M | - | - |
| Inventory | 0.00M | 0.06M | 0.22M | 0.28M | 0.38M |
| Non currrent assets other | - | - | - | - | 0.10M |
| Non current assets total | 0.00M | 1.83M | 2.50M | 1.92M | 3.75M |
| Capital lease obligations | 0.00M | 1.26M | 1.48M | 0.66M | 0.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | 4.00M | -4.02M | 0.00M |
| Net borrowings | -1.20M | -0.86M | -0.21M | -0.72M | -0.64M |
| Total cash from financing activities | 27.43M | 0.79M | -0.25M | -0.72M | 34.13M |
| Net income | -1.37M | -6.19M | -13.03M | -14.81M | -6.14M |
| Change in cash | 27.17M | -2.86M | -7.77M | -19.14M | 14.22M |
| Begin period cash flow | 0.33M | 3.15M | 11.01M | 30.12M | 15.89M |
| End period cash flow | 27.46M | 0.33M | 3.15M | 11.01M | 30.12M |
| Total cash from operating activities | -3.63M | -3.72M | -10.98M | -13.86M | -18.23M |
| Issuance of capital stock | 30.00M | 1.91M | 0.00M | 0.00M | 26.73M |
| Depreciation | 0.03M | 1.39M | 1.83M | 2.65M | 3.19M |
| Change to inventory | 0.01M | 0.17M | 0.06M | - | - |
| Change to account receivables | -0.02M | 0.13M | 0.12M | - | - |
| Capital expenditures | 0.00M | 0.02M | 0.62M | 0.68M | 1.77M |
| Change in working capital | 0.22M | 0.76M | -0.21M | 0.13M | -0.32M |
| Stock based compensation | 0.09M | 0.30M | 0.42M | 1.46M | 1.70M |
| Other non cash items | -2.75M | 0.16M | 0.02M | 0.47M | 0.03M |
| Free cash flow | -3.63M | -3.74M | -11.60M | -14.54M | -19.99M |
Sector: Energy Industry: Oil & Gas Midstream
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ATLE Atlas Energy Corp. |
- -% |
0.09 | - | 69.44 | 12.30 | 3.81 | 21.72 | -332.50 |
| SRR Source Rock Royalties Ltd |
-0.02 1.79% |
1.10 | 32.67 | - | 7.41 | 1.89 | 6.64 | 8.68 |
Atlas Energy Corp., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. The company was formerly known as Willow Biosciences Inc. and changed its name to Atlas Energy Corp. in June 2025. Atlas Energy Corp. was founded in 2019 and is headquartered in Calgary, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Travis Doupe | Chief Financial Officer | 1971 |
| Mr. Mark Alan Hodgson | President, CEO & Director | 1980 |
| Mr. Ryan Giroux | Vice President of Corporate Development | 1977 |
| Mr. Blair L. Anderson | Vice President of Geoscience | 1954 |
| Mr. Sanjib Singh Gill L.L.B. | Corporate Secretary | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.